Press Releases
 
Asthma and COPD Drugs Market Opportunity will Rise to US$ 18.7 Bn by 2024

Transparency Market Research Report Added "Asthma and COPD Drugs Market" to its database.

Albany NY, 11 October 2018 -- The opportunity in the U.S. and China asthma and COPD drugs market is slated to rise from a valuation of US$13.0 bn in 2015 to be worth US$18.7 bn by 2024. If these values hold true, asthma and COPD drugs market is likely to expand at a modest CAGR of 4.1% therein.

U.S. and China Asthma and COPD Drugs Market: Snapshot

The U.S. and China market for asthma and chronic obstructive pulmonary disease (COPD) drugs is expected to exhibit growth at a steady pace in the next few years. Factors such as a significant rise prevalence of COPD and asthma in these two countries, advancements in diagnostic methods, and rising awareness among patients regarding the available treatment methods are considered key to the overall growth of the market over the period 2016–2024.

Report Overview @ https://www.transparencymarketresearch.com/us-china-asthma-copd-drugs-market.html

The market is expected to exhibit growth at a moderate pace in the first few years of the forecast period, chiefly owing to the patent expiries of leading drugs and the subsequent price erosion. However, the market is expected to witness new drug candidates by 2020, which will help the market tread along a better growth path in the forthcoming years.

Transparency Market Research estimates that the market will exhibit a 4.1% CAGR from 2016 through 2024, rising to a valuation of US$18.7 bn by 2024 from US$13.0 bn in 2015.

Combination Drugs Sales to Constitute Bulk of Revenue

On the basis of drug classes in the U.S. and China asthma and COPD drugs market, the report examines the future scope of growth for varieties such as bronchodilators, anti-inflammatory drugs, monoclonal antibodies, and combination drugs.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=15857

Of these, the segment of combination drugs is presently the leading segment. It accounted for a 54% of the U.S. and China asthma and COPD drugs market in 2015 and is expected to continue to dominate throughout the report’s forecast period. Combination drugs benefit from the recommendations from agencies such as Global Initiative for Chronic Obstructive Lung Disease (GOLD) and Global Initiative for Asthma (GINA), which regard combination drugs as the safer course of managing asthma and COPD.

The segment of monoclonal antibodies is expected to emerge as a prominent drug class for the management of asthma and COPD in the next few years. Emergence of new drug candidates in this segment will bolster its growth potential in the market during the report’s forecast period.
us china asthma copd drugs market

High Costs of Asthma and COPD Drugs and Consumer Awareness make U.S. the Clear Leader

In the U.S. and China market for asthma and COPD drugs, the U.S. market clearly dominates, accounting for a more than 81% of the overall market in 2016. The key factors to have benefitted the U.S. market, despite it being a relatively smaller market in terms of population, include the high costs of asthma and COPD drugs and a high level of attentiveness paid by consumers to healthcare and wellness. The U.S. market also contributes significantly to the overall asthma and COPD drugs market through regular product launches and high investments by leading companies for R&D in the areas of combination therapies and biologics.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15857

Although China presently accounts for a relatively smaller share in the U.S. and China asthma and COPD drugs market, the country is expected to present attractive growth opportunities in the next few years. The China market for asthma and COPD drugs will exhibit an impressive 10% CAGR over the period between 2016 and 2024. The key factors attributable to this projection are the rising number of asthma patients, owing chiefly to rising levels of air pollution, and a vast array of unmet medical needs.

The rising prevalence of COPD in the country is chiefly owing to the high and rising number of smokers. The China market for asthma and COPD drugs also comes across as a more attractive market than the U.S. market owing to a low level of competition and high rate of growth.

Some of the leading vendors presently operating in the U.S. and China asthma and COPD drugs market profiled in the report are Boehringer Ingelheim, GlaxoSmithKline plc, Merck and Co., Inc., Novartis AG, AstraZeneca plc, and F. Hoffmann-La Roche.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email:

Website: https://www.transparencymarketresearch.com

# # #


Submitted by hawer on Thursday, 11 October 2018 at 7:28 PM
Category: Health Care & Medical
 
Related News

Human Growth Hormone Market: Rising Incidences of Chronic Conditions to Propel the Market Growth
Thursday, 17 Jan 2019

Diabetes Drugs Market: Introduction of Improved Drugs to Accentuate the Growth
Thursday, 17 Jan 2019

Chronic Myelogenous Leukemia Treatment Market to bring in US$ 8,550.8 Million Revenue by 2026 End
Wednesday, 16 Jan 2019

Pharmaceutical Continuous Manufacturing Market to Expand with a CAGR of 8.8% from 2017 to 2025
Wednesday, 16 Jan 2019

Prefilled Safety Devices Market is Projected to Expand at a Steady CAGR Over the Forecast Period 202
Wednesday, 16 Jan 2019

Related Events

Pre-Filled Syringes And Injectable Drug Devices Europe
Wednesday, 16 Jan 2019

11th Annual ICJR Winter Hip and Knee Course, Vail 2019
Thursday, 17 Jan 2019

ICRS Summit, San Diego, 2019 - Bio/Orthopaedics in Sport Medicine
Thursday, 17 Jan 2019

9th Annual Orthopaedic Trauma and Fracture Care: Pushing the Envelope
Thursday, 17 Jan 2019

Breast Ultrasound CME Course with Tom Stavros, San Antonio 2019
Friday, 18 Jan 2019

Latest News

Time to Enjoy The Changes of RS Mining&Smithing with Up to 9% off rsgold Jan.20-Jan.27
Thursday, 17 Jan 2019

Direct Way to Kill OSRS Hespori Boss with Up to 9% off rs gold 07 Jan.20-Jan.27
Thursday, 17 Jan 2019

Excellent Bead Jewelry Designs
Thursday, 17 Jan 2019

100 Free Dating Sites - Tips To Use Free Dating Sites And Save Money
Thursday, 17 Jan 2019

TIC-TOC technology moves Tactile Internet a step closer to reality
Thursday, 17 Jan 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Thursday, 17 January 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: GO FAST, STAY SECURE - Security for Public Clouds
  • Automated Endoscope Reprocessors (AER) Market Size, Share, Growth and Forecast 2026
  • London Art Fair
  • Pre-Filled Syringes And Injectable Drug Devices Europe
  • Property Deal Network Leeds - Property Investor Meet up

  • Latest Jobs
    Sorry, there are currently no entries posted here.